0001771910 1 2026-03-10 2026-03-10 0001771910 2026-03-10 2026-03-10 iso4217:USD pure shares S-3 EX-FILING FEES 0001771910 N/A N/A S-3 ADC Therapeutics SA false Equity Common Shares true 9834776 4.12 40519277.12 0.0001381 5595.71 40519277.12 5595.71 5595.71 Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low sale prices for common shares as reported on the New York Stock Exchange on March 5, 2026.<br/><br/>Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, the Registrant is also registering hereunder an indeterminate number of common shares that may be issued in connection with anti-dilution provisions or stock splits, stock dividends or similar transactions. <br/>